These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12744241)

  • 1. Discussion on the effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
    Waldum H; Berenna E
    Gastroenterology; 2003 May; 124(5):1564-5; author reply 1565. PubMed ID: 12744241
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussion on the effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
    Cattan D
    Gastroenterology; 2003 Aug; 125(2):627; author reply 627-8. PubMed ID: 12891576
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas.
    Peghini PL; Annibale B; Azzoni C; Milione M; Corleto VD; Gibril F; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
    Gastroenterology; 2002 Jul; 123(1):68-85. PubMed ID: 12105835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective surgical management of correctable hypergastrinemia.
    Delcore R; Hermreck AS; Friesen SR
    Surgery; 1989 Dec; 106(6):1094-100; discussion 1100-2. PubMed ID: 2573956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin processing in primary culture of gastrinoma cells.
    Sobhani I; Elouaer-Blanc L; Pauwels S; Lehy T; Rahier J; Mignon M; Bonfils S; Lewin MJ
    Horm Res; 1989; 32(1-3):71-3. PubMed ID: 2482243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract.
    Gurevich L; Kazantseva I; Isakov VA; Korsakova N; Egorov A; Kubishkin V; Bulgakov G
    Cancer; 2003 Nov; 98(9):1967-76. PubMed ID: 14584081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy.
    Donow C; Pipeleers-Marichal M; Schröder S; Stamm B; Heitz PU; Klöppel G
    Cancer; 1991 Sep; 68(6):1329-34. PubMed ID: 1678681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas.
    Fendrich V; Ramerth R; Waldmann J; Maschuw K; Langer P; Bartsch DK; Slater EP; Ramaswamy A; Rothmund M
    Endocr Relat Cancer; 2009 Jun; 16(2):613-22. PubMed ID: 19240184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of gastrinomas by immunohistochemistry and in situ hybridization histochemistry.
    Perkins PL; McLeod MK; Jin L; Fukuuchi A; Cho KJ; Thompson NW; Lloyd RV
    Diagn Mol Pathol; 1992 Sep; 1(3):155-64. PubMed ID: 1285276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
    Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
    Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anomalies of fundic argyrophil cell proliferation (enterochromaffin-like cells) in Zollinger-Ellison syndrome].
    Cadiot G; Lehy T; Ruszniewski P; Sobhani I; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):41C-46C. PubMed ID: 1916118
    [No Abstract]   [Full Text] [Related]  

  • 12. Rebound hypergastrinemia after cessation of a somatostatin analogue (SMS 201-995) in malignant gastrinoma.
    Buck M; Kvols LK; O'Dorisio TM
    Am J Med; 1987 May; 82(5B):92-5. PubMed ID: 2884883
    [No Abstract]   [Full Text] [Related]  

  • 13. Cat gastrinoma and the sequence of cat gastrins.
    Eng J; Du BH; Johnson GF; Kanakamedala S; Samuel S; Raufman JP; Straus E
    Regul Pept; 1992 Jan; 37(1):9-13. PubMed ID: 1585019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The consequences of hypergastrinemia.
    Creutzfeldt W
    Yale J Biol Med; 1994; 67(3-4):181-94. PubMed ID: 7502528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.
    Rosentraeger MJ; Garbrecht N; Anlauf M; Raffel A; Knoefel WT; Wiedenmann B; Klöppel G
    Virchows Arch; 2016 Mar; 468(3):277-87. PubMed ID: 26649731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.
    Hirschowitz BI; Worthington J; Mohnen J; Haber M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):869-78. PubMed ID: 17767471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma.
    Jensen RT; Fraker DL
    JAMA; 1994 May; 271(18):1429-35. PubMed ID: 7513768
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pancreatic endocrine tumor--from clinic to calcium sensing receptor].
    Imamura M
    Hum Cell; 2000 Jun; 13(2):65-9. PubMed ID: 10976408
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic hypergastrinemia: causes and consequences.
    Orlando LA; Lenard L; Orlando RC
    Dig Dis Sci; 2007 Oct; 52(10):2482-9. PubMed ID: 17415644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.